Condition
Carbapenem-Resistant Enterobacteriaceae Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Carbapenem-Resistant Enterobacteriaceae Infection clinical trials that are recruiting, at sites in 11 countries (most in China (3), Argentina (1), Hong Kong (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 11Countries
Newest Carbapenem-Resistant Enterobacteriaceae Infection clinical trials
All recruiting trials (7)
-
Aztreonam-Avibactam in Immunocompromised Patients with Multidrug-Resistant Infections
This study tests how well and how safely aztreonam-avibactam works in adults with weakened immune systems who have highly resistant Enterobacterales infections.
-
Jet versus vibrating mesh inhalation of polymyxin B for ventilated patients with carbapenem‑resistant Gram‑negative pneumonia
This trial tests whether jet nebulizers or vibrating mesh nebulizers deliver inhaled polymyxin B more effectively for mechanically ventilated patients with carbapenem‑resistant Gram‑negative pneumonia.
-
Using Colistimethate Sodium to Treat Infections from Carbapenem-Resistant Bacteria
This study is testing if colistimethate sodium can help hospitalized patients with infections from tough-to-treat bacteria feel better compared to standard treatments.
-
Early treatment with targeted antibiotics for severe infections using rapid diagnostics
This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.
-
Reducing the spread of antibiotic-resistant infections from hospitals to communities
This study is testing a set of strategies to see if they can help stop the spread of antibiotic-resistant infections from hospitals to families and communities.
-
Identifying risk factors for infections in children with drug-resistant bacteria
This study looks at children in the hospital to see what factors might lead to infections from tough-to-treat bacteria called carbapenem-resistant Enterobacteriaceae.
-
Using fecal microbiota transplantation to treat gut disorders
This study is testing whether a treatment that involves using healthy stool to help restore gut bacteria can improve symptoms for people with gut disorders like Crohn's disease and irritable bowel syndrome.
Related topics
Quick answers
How many Carbapenem-Resistant Enterobacteriaceae Infection clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (3 trials), Argentina (1 trial), Hong Kong (1 trial), Vietnam (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.